Sentence examples for clinical trial programme from inspiring English sources
We acted properly and responsibly in the way the clinical trial programme for Avandia was run, in marketing it, monitoring for safety and in the updates we put out.
To date, the PREEMPT clinical trial programme is the largest study of onabotulinumtoxinA in CM and provides evidence for safety and efficacy over a 52-week treatment period [23 25].
The PREEMPT 56-week clinical trial programme was the largest clinical programme investigating the use of OnabotulinumtoxinA as a prophylactic treatment for chronic migraine using a defined set of diagnostic criteria and defined clinically relevant outcome measures.
OnabotulinumtoxinA is currently approved for the treatment of CM in most European countries, and is the only preventative treatment approved for adults with CM, based on results from the PREEMPT clinical trial programme.
It is noteworthy that recurrence was not perceived as a "specific clinical problem" in migraine therapy before the advent of sumatriptan in the large clinical trial programme which resulted in its introduction into clinical use of the drug [2].
A European patient registry (ARIEL) for Adept® use was established alongside the formal clinical trial programme, providing surgeons' feedback on the use and safety of Adept® in routine open and laparoscopic gynaecological [64] and general surgery [65] in 4,620 patients 2,882 of whom underwent gynaecological surgery (2,069 laparoscopy, 813 laparotomy).
Objectives: To review currently available self-report instruments for the assessment of male sexual function; to consider their utility for comprehensive assessments across all domains of sexual function, and suitability for wide-scale administration in clinical trial programmes.
Much time, money and effort on behalf of patients, doctors, statisticians, pharmaceutical personnel and regulators are spent in planning and undertaking clinical trial programmes that result in antiepileptic drugs reaching the marketplace and thereafter becoming available for treating people with epilepsy in everyday clinical practice.
In this way, the increasing demands of regulators that have led to increasing complexity of clinical trial programmes are highly relevant to the increase in clinical trial periods we have observed.
This may be expected given the long lead times for planning and conducting clinical trial programmes, though further analysis shows no association between the duration of clinical development and the year when clinical development started (r=0.04, y=−0.16+399.67, p=0.80).
